Rosuvastatin S-Isomer is the enantiomerically pure S-configured stereoisomer of Rosuvastatin, differing in the absolute configuration at the chiral sulfoxide center. It retains the core structure comprising a pyridine-fused dihydropyridine ring, a fluorinated cyclopropylmethyl substituent, and a calcium-coordinated sulfone moiety. This impurity arises from partial stereoselective synthesis during API manufacturing, resulting in residual S-enantiomer enrichment. It serves as an HPLC reference standard for enantiomeric purity profiling in quality control.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| EP | Y0001719 โ | 160 MG | EUR 90.00 |
| EP | Y0001721 โ | 15 MG | EUR 90.00 |
| USP | 1606015 โ | 300 mg | USD 939.00 |
CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.[Ca+2]
InChI=1S/2C22H28FN3O6S.Ca/c2*1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32;/h2*5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30);/q;;+2/p-2/b2*10-9+;/t2*16-,17-;/m11./s1
LALFOYNTGMUKGG-BGRFNVSISA-L